Prescribing Patterns of Dupilumab for Atopic Dermatitis in Adults: Retrospective, Observational Cohort Study
BackgroundAtopic dermatitis (AD) is a common inflammatory disease caused by a type 2 T helper cell–mediated immune response to environmental antigens. Approximately 1 in 5 patients with AD presents with moderate to severe disease, and treatments approved by the Food and Drug...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2023-08-01
|
Series: | JMIR Dermatology |
Online Access: | https://derma.jmir.org/2023/1/e41194 |